|
1
|
Frazier Life Sciences Management
Palo Alto,
California
|
$30.9M
|
+$5.46M
|
+3,184,164
|
+16%
|
|
|
2
|
T. Rowe Price Investment Management
Baltimore,
Maryland
|
$23.7M
|
+$999K
|
+581,817
|
+3%
|
|
|
3
|
|
$22.2M
|
–
|
–
|
–
|
|
|
4
|
|
$21.4M
|
-$279K
|
-162,556
|
-1%
|
|
|
5
|
Logos Global Management
San Francisco,
California
|
$17.8M
|
+$858K
|
+500,000
|
+4%
|
|
|
6
|
Vanguard Group
Malvern,
Pennsylvania
|
$17.4M
|
+$91.9K
|
+53,525
|
+0.4%
|
|
|
7
|
Suvretta Capital Management
New York
|
$16.9M
|
–
|
–
|
–
|
|
|
8
|
Arch Venture Management
Chicago,
Illinois
|
$15.1M
|
–
|
–
|
–
|
|
|
9
|
Paradigm Biocapital Advisors
New York
|
$14.8M
|
+$85.8K
|
+50,000
|
+0.5%
|
|
|
10
|
Siren LLC
Greenwich,
Connecticut
|
$12M
|
-$172K
|
-99,930
|
-1%
|
|
|
11
|
Silverarc Capital Management
Boston,
Massachusetts
|
$10.1M
|
-$302K
|
-175,905
|
-2%
|
|
|
12
|
Vivo Capital
Palo Alto,
California
|
$9.26M
|
–
|
–
|
–
|
|
|
13
|
5AM Venture Management
San Francisco,
California
|
$7.41M
|
–
|
–
|
–
|
|
|
14
|
Octagon Capital Advisors
New York
|
$7.04M
|
–
|
–
|
–
|
|
|
15
|
Geode Capital Management
Boston,
Massachusetts
|
$6.52M
|
+$323K
|
+188,033
|
+4%
|
|
|
16
|
State Street
Boston,
Massachusetts
|
$5.72M
|
-$4.17M
|
-2,431,596
|
-37%
|
|
|
17
|
Woodline Partners
San Francisco,
California
|
$5.68M
|
+$271
|
+158
|
+0%
|
|
|
18
|
PFM Health Sciences
San Francisco,
California
|
$4.78M
|
-$1.55M
|
-900,868
|
-21%
|
|
|
19
|
Affinity Asset Advisors
New York
|
$4.58M
|
+$1.45M
|
+842,088
|
+34%
|
|
|
20
|
Millennium Management
New York
|
$4.42M
|
-$1.64M
|
-953,382
|
-23%
|
|
|
21
|
AH Capital Management
Menlo Park,
California
|
$3.92M
|
–
|
–
|
–
|
|
|
22
|
Soleus Capital Management
Greenwich,
Connecticut
|
$2.96M
|
–
|
–
|
–
|
|
|
23
|
Marshall Wace
London,
United Kingdom
|
$2.78M
|
–
|
–
|
–
|
|
|
24
|
Bank of America
Charlotte,
North Carolina
|
$2.67M
|
+$5.24K
|
+3,052
|
+0.2%
|
|
|
25
|
|
$2.65M
|
-$1.49M
|
-865,373
|
-31%
|
|
